These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6133314)
1. The natural history of coronary artery disease: does medical therapy improve the prognosis? Goldman GJ; Pichard AD Prog Cardiovasc Dis; 1983; 25(6):513-52. PubMed ID: 6133314 [No Abstract] [Full Text] [Related]
2. Effective drugs in preventing recurrent coronary events. II. Late management. Rapaport E Adv Cardiol; 1986; 33():9-16. PubMed ID: 2882653 [No Abstract] [Full Text] [Related]
3. [Effects of medical therapy on long-term survival in ischemic heart disease]. Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332 [No Abstract] [Full Text] [Related]
4. Drugs and the heart. VII. Which drug for which disease? Opie LH Lancet; 1980 May; 1(8176):1011-7. PubMed ID: 6103335 [No Abstract] [Full Text] [Related]
5. [Intervention in ischemic heart disease and myocardial infarction. 3. Medical intervention]. Pedersen A Ugeskr Laeger; 1982 Jul; 144(29):2156-64. PubMed ID: 6128809 [No Abstract] [Full Text] [Related]
6. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
7. Therapeutic choices in unstable angina. Gottlieb SO; Gerstenblith G Am J Med; 1986 Apr; 80(4C):35-9. PubMed ID: 2871756 [TBL] [Abstract][Full Text] [Related]
8. Effect of long-term prophylactic treatment on survival after myocardial infarction. Furberg CD; May GS Am J Med; 1984 Jun; 76(6A):76-83. PubMed ID: 6146258 [TBL] [Abstract][Full Text] [Related]
10. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects]. Delius W Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156 [No Abstract] [Full Text] [Related]
11. Calcium channel blockers or beta receptor antagonists for patients with ischaemic heart disease. What is the best choice? Rydén L; Malmberg K Eur Heart J; 1996 Jan; 17(1):1-3. PubMed ID: 8682115 [No Abstract] [Full Text] [Related]
12. [Treatment of the intermediate syndrome]. Mady C; Macruz R Arq Bras Cardiol; 1979 Feb; 32(2):71-4. PubMed ID: 37821 [No Abstract] [Full Text] [Related]
13. Calcium channel blockers: indications and limitations 2. Use in angina and other cardiac disorders. Karlsberg RP; Aronow WS Postgrad Med; 1982 Nov; 72(5):115-7, 120, 123. PubMed ID: 6215636 [TBL] [Abstract][Full Text] [Related]
15. Secondary prevention trials after acute myocardial infarction. Furberg CD Am J Cardiol; 1987 Jul; 60(2):28A-32A. PubMed ID: 2887098 [TBL] [Abstract][Full Text] [Related]
16. [Secondary prevention of myocardial infarct]. Kotsev G Vutr Boles; 1984; 23(2):55-9. PubMed ID: 6146228 [No Abstract] [Full Text] [Related]
17. Medical management of stable angina and unstable angina in the elderly with coronary artery disease. Olson HG; Aronow WS Clin Geriatr Med; 1996 Feb; 12(1):121-40. PubMed ID: 8653654 [TBL] [Abstract][Full Text] [Related]
18. Beta blocking agents: current status in the prevention of sudden coronary death. Hjalmarson A Ann N Y Acad Sci; 1982; 382():305-23. PubMed ID: 6123286 [No Abstract] [Full Text] [Related]
19. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs]. Noll G; Kaufmann U; Wenzel RR; Lüscher TF Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687 [TBL] [Abstract][Full Text] [Related]
20. [What is safe in the therapy of hypertensive heart disease?]. Motz W; Strauer BE Internist (Berl); 1985 Dec; 26(12):750-64. PubMed ID: 2867983 [No Abstract] [Full Text] [Related] [Next] [New Search]